Skip to main content
    Physician-selected

    Retatrutide,
    when your physician selects it.

    We offer retatrutide as a gated option inside ELEVATED GLP-1 after your $79 Wellness Assessment. Semaglutide and tirzepatide remain the headline programs. It is not FDA-approved, and it is never sold as a self-serve checkout.

    See headline GLP-1 programs

    $79

    Wellness Assessment in Evans. Credited toward a qualifying program if you enroll.

    $499/mo

    ELEVATED GLP-1 · Retatrutide. Physician decision only — not a self-serve checkout.

    Sema / Tirz

    Semaglutide and tirzepatide remain the primary ELEVATED GLP-1 offers.

    Named, gated, and not a click-to-buy.

    Patients ask whether we have retatrutide. We do — as a physician-selected option inside the GLP-1 lane, with the same in-person Evans care as every ELEVATED program.

    • Investigational triple-receptor agonist (GIP / GLP-1 / glucagon)
    • Offered only after the $79 Wellness Assessment
    • Requires GLP-1 informed consent with Section 11A
    • Sourced only through our designated 503A pharmacy if prescribed
    • Not the headline weight-loss offer
    • Not available as online self-checkout
    • Not a wait list or early-access list
    • Not a claim that compounding is FDA-authorized

    Investigational medication

    Retatrutide is investigational. It is not FDA-approved for any use. The FDA has stated that retatrutide does not qualify for pharmacy compounding exemptions under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, and has warned firms marketing compounded or “research” retatrutide. Offering it here is a physician clinical decision after your Wellness Assessment. That decision does not change federal law. If prescribed, it is sourced only through our designated 503A compounding pharmacy — never gray-market or research-only vendors. Semaglutide and tirzepatide remain the headline ELEVATED GLP-1 programs. Individual results vary.

    Same front door as every consult-gated program.

    01

    Wellness Assessment ($79)

    In-person visit in Evans. History, medications, and whether any GLP-1 path — including this option — is appropriate.

    02

    Physician review

    Your physician decides. Retatrutide is never self-selected online and is not offered as a wait-list or à la carte click-to-buy.

    03

    Consent

    If selected, you sign the GLP-1 consent including Section 11A — investigational status, not FDA-approved, and the FDA compounding position.

    04

    Ongoing program care

    $499/mo includes medication when prescribed, monthly check-ins, quarterly labs, and messaging. Dose changes stay with your clinician.

    Questions, answered.

    Ask about it at your assessment.

    Retatrutide is not available for self-selection or online checkout. Your physician decides after the Wellness Assessment.

    Or call (706) 760-3470